Manufacturers are reporting shortages of a common medication for sexually transmitted disease (STDs); rates of cancers related to human papillomavirus (HPV) increased from 2007 to 2016; early trial data show patients infected with coronavirus disease 2019 (COVID-19) respond to remdesivir.
After President Trump promoted a commonly prescribed antibiotic for sexually transmitted diseases (STDs) as a potential cure for coronavirus disease 2019 (COVID-19), suppliers of azithromycin tablets (Z-Packs) have been struggling to meet the demand, The Hill reports. The FDA loosened restrictions on how the drug can be used and as a result, some doctors are combining azithromycin with hydroxychloriquine—an anti-malarial medication—to treat patients with COVID-19. However, azithromycin is currently the only approved treatment for chlamydia in pregnant women; there is little evidence that the 2-drug combination is effective against the virus, although trials are underway.
According to a new CDC report, rates of oral and pharynx cancers increased from around 35,000 cases in 2007 to nearly 45,000 cases in 2016. The increase was driven by high rates of human papillomavirus (HPV)-associated cancers, researchers said. In particular, tonsil and oropharynx cancers caused by HPV increased by more than 2% per year. In comparison, non-HPV-associated cancer rates decreased by around 0.4% each year. Researchers note public health efforts focused on HPV vaccination will be essential to prevent future increases.
An early report of partial, incomplete data of Gilead’s remdesivir shows it could be an effective treatment for patients with COVID-19, according to Reuters. A University of Chicago hospital participating in the clinical trial said it is seeing rapid symptom recoveries, with the majority of patients being discharged in less than a week after receiving treatment. Complete results from the phase 3 study will become available at the end of the month, and researchers emphasize partial data should not be used to draw conclusions. In addition, there is no control group and the patient sample size is small.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
2 Commerce Drive
Cranbury, NJ 08512